Clinical Laboratory Tests Market Driver, Trends, Applications & Business Strategy Forecast 2027

Clinical Laboratory Tests Industry Overview

The global clinical laboratory tests market size is expected to reach USD 304.9 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.1% over the forecast period. Introduction of new solutions for minimizing errors and maximizing efficiency is anticipated to boost the overall market growth.

U.S. clinical laboratory tests market

Clinical Laboratory Tests Market Segmentation

Grand View Research has segmented the global clinical laboratory tests market on the basis of type, end use, and region:

Based on the Type Insights, the market is segmented into Complete blood count, HGB/HCT, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel, Liver panel, Renal panel and Lipid panel.

  • Basic metabolic tests accounted for a significant share of the global market for clinical laboratory tests in 2019 owing to the increasing prevalence of lifestyle-induced diseases, including metabolic abnormalities and obesity.
  • Lipid panel tests is estimated to be the fastest-growing segment over the forecast period due to increasing awareness about the prevalence of cardiovascular disorders and diabetes.
  • The liver panel segment has been further divided into liver cirrhosis, hepatitis, liver cancer, bone disease, bile duct obstruction, and autoimmune disorders. 

Based on the End-use Insights, the market is segmented into Central Laboratories and Primary Clinics.

  • In 2019, central laboratories dominated the market. The primary clinics segment is estimated to register a significant growth rate over the forecast period owing to increasing demand for rapid test results. Growing awareness about laboratory tests in clinics among patients and physicians is estimated to drive the segment over the forecast period.

Clinical Laboratory Tests Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Companies Profile & Market Share Insights

Key companies are focusing on strategic partnerships, mergers, and acquisitions to increase their presence in the market for clinical laboratory tests. For instance, Charles River acquired MPI research in 2018, a premier non-clinical contract research organization that provides comprehensive testing services to different biopharmaceutical and medical device companies. 

Some prominent players in the global clinical laboratory tests market include:

  • Abbott
  • ARUP Laboratories
  • OPKO Health, Inc.
  • Bioscientia Institut für Medizinische Diagnostik GmbH
  • Charles River
  • NeoGenomics Laboratories, Inc.
  • Genoptix, Inc.
  • Healthscope Ltd.
  • Labco
  • Laboratory Corporation of America Holdings (LabCorp)
  • Fresenius Medical Care
  • QIAGEN
  • Quest Diagnostics
  • Siemens Healthcare Private Limited
  • Tulip Diagnostics (P) Ltd.
  • Sonic Healthcare
  • Merck KgaA
  • Biosino Bio-technology and Science Inc.

Order a free sample PDF of the Clinical Laboratory Tests Market Intelligence Study, published by Grand View Research.

Comments are closed